Fuling Zhou to Heterografts
This is a "connection" page, showing publications Fuling Zhou has written about Heterografts.
Connection Strength
0.182
-
Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs/ROS/Trx1 signalling pathway. J Exp Clin Cancer Res. 2018 Nov 19; 37(1):277.
Score: 0.182